Notice2023-00911
Notice of Meeting
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
January 19, 2023
Issuing agencies
Health and Human Services DepartmentSubstance Abuse and Mental Health Services Administration
Full Text
<html>
<head>
<title>Federal Register, Volume 88 Issue 12 (Thursday, January 19, 2023)</title>
</head>
<body><pre>
[Federal Register Volume 88, Number 12 (Thursday, January 19, 2023)]
[Notices]
[Page 3428]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2023-00911]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Substance Abuse and Mental Health Services Administration
Notice of Meeting
Pursuant to Public Law 92-463, notice is hereby given that the
Substance Abuse and Mental Health Services Administration's (SAMHSA)
Center for Substance Abuse Prevention's (CSAP) Drug Testing Advisory
Board (DTAB) will convene via web conference on March 7, 2023, from 10
a.m. EST to 4:30 p.m. EST.
The board will meet in open-session March 7, 2023, from 10 a.m. EST
to 2 p.m. EST to discuss the Mandatory Guidelines for Federal Workplace
Drug Testing Programs, updates to the Electronic Chain of Custody Form
(ECCF), as well as updates from the Department of Transportation, the
Nuclear Regulatory Commission, the Department of Defense, and the Food
and Drug Administration as well as a presentation by Dr. Svante
Vikingsson on Fentanyl and Opioids Pulse Study results.
The board will meet in closed session on March 7, 2023, from 2:15
p.m. EST to 4:30 p.m. EST to discuss issues surrounding cannabinoids
pertaining to the effect of the proliferation of various cannabinoid
isomers, including Delta-8-THC, on federal workplace drug testing
programs, including federal and state responses to cannabinoid drug
testing issues of concern, and potential SAMSHA actions. In closed
session the board will also review information and proposed actions
concerning the Department of Health and Humans Services (HHS) Mandatory
Guideline internal review and approval process that has not been made
public by HHS. Therefore, the March 7, 2023, meeting from 2:15 p.m. to
4:30 p.m. is closed to the public, as determined by the Assistant
Secretary for Mental Health and Substance Use, SAMHSA, in accordance
with 5 U.S.C. 552b(c)(9)(B) and 5 U.S.C. App. 2, section 10(d).
Meeting registration information can be completed at <a href="https://snacregister.samhsa.gov/">https://snacregister.samhsa.gov/</a>. Web conference and call information will be
sent after completing registration. Meeting information and a roster of
DTAB members may be obtained by accessing the SAMHSA Advisory
Committees website, <a href="https://www.samhsa.gov/about-us/advisory-councils/meetings">https://www.samhsa.gov/about-us/advisory-councils/meetings</a>, or by contacting the Designated Federal Officer, Lisa Davis.
Committee Name: Substance Abuse and Mental Health Services
Administration, Center for Substance Abuse Prevention, Drug Testing
Advisory Board.
Dates/Time/Type: March 7, 2023, from 10 a.m. EST to 2 p.m. EST:
OPEN; March 7, 2023, from 2:15 p.m. EST to 4:30 p.m. EST: CLOSED.
Place: Substance Abuse and Mental Health Services Administration,
5600 Fishers Lane, Rockville, MD 20857.
Contact: Lisa S. Davis, M.S., Social Science Analyst, Center for
Substance Abuse Prevention, 5600 Fishers Lane, Rockville, Maryland
20857, Telephone: (240) 276-1440, Email: <a href="/cdn-cgi/l/email-protection#fdb1948e9cd3b99c8b948ebd8e9c90958e9cd395958ed39a928b"><span class="__cf_email__" data-cfemail="65290c16044b2104130c16251604080d16044b0d0d164b020a13">[email protected]</span></a>.
Anastasia Marie Donovan,
Public Health Advisor, Division of Workplace Programs.
[FR Doc. 2023-00911 Filed 1-18-23; 8:45 am]
BILLING CODE 4162-20-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on January 19, 2023.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.